469 related articles for article (PubMed ID: 26806172)
1. Delivering anti-cancer drugs with endosomal pH-sensitive anti-cancer liposomes.
Moku G; Gulla SK; Nimmu NV; Khalid S; Chaudhuri A
Biomater Sci; 2016 Apr; 4(4):627-38. PubMed ID: 26806172
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanoma.
Reddy TL; Garikapati KR; Reddy SG; Reddy BV; Yadav JS; Bhadra U; Bhadra MP
Sci Rep; 2016 Oct; 6():35223. PubMed ID: 27786239
[TBL] [Abstract][Full Text] [Related]
3. pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells.
Yang Z; Sun N; Cheng R; Zhao C; Liu Z; Li X; Liu J; Tian Z
Biomaterials; 2017 Dec; 147():53-67. PubMed ID: 28930649
[TBL] [Abstract][Full Text] [Related]
4. Curcumin loaded pH-sensitive hybrid lipid/block copolymer nanosized drug delivery systems.
Jelezova I; Drakalska E; Momekova D; Shalimova N; Momekov G; Konstantinov S; Rangelov S; Pispas S
Eur J Pharm Sci; 2015 Oct; 78():67-78. PubMed ID: 26159739
[TBL] [Abstract][Full Text] [Related]
5. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting.
Raza F; Zhu Y; Chen L; You X; Zhang J; Khan A; Khan MW; Hasnat M; Zafar H; Wu J; Ge L
Biomater Sci; 2019 Apr; 7(5):2023-2036. PubMed ID: 30839983
[TBL] [Abstract][Full Text] [Related]
7. Tumor growth inhibition through targeting liposomally bound curcumin to tumor vasculature.
Mondal G; Barui S; Saha S; Chaudhuri A
J Control Release; 2013 Dec; 172(3):832-40. PubMed ID: 24036260
[TBL] [Abstract][Full Text] [Related]
8. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
[TBL] [Abstract][Full Text] [Related]
9. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR
Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163
[TBL] [Abstract][Full Text] [Related]
10. Dehydroascorbic Acid and pGPMA Dual Modified pH-Sensitive Polymeric Micelles for Target Treatment of Liver Cancer.
Ma H; Jiang C
J Pharm Sci; 2018 Feb; 107(2):595-603. PubMed ID: 29024701
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid coated Pluronic F127/Pluronic P123 mixed micelle for targeted delivery of Paclitaxel and Curcumin.
Anirudhan TS; Varghese S; Manjusha V
Int J Biol Macromol; 2021 Dec; 192():950-957. PubMed ID: 34662655
[TBL] [Abstract][Full Text] [Related]
12. Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition.
Chen D; Lian S; Sun J; Liu Z; Zhao F; Jiang Y; Gao M; Sun K; Liu W; Fu F
Drug Deliv; 2016; 23(3):808-13. PubMed ID: 24892632
[TBL] [Abstract][Full Text] [Related]
13. A dual pH-sensitive liposomal system with charge-reversal and NO generation for overcoming multidrug resistance in cancer.
Chen M; Song F; Liu Y; Tian J; Liu C; Li R; Zhang Q
Nanoscale; 2019 Mar; 11(9):3814-3826. PubMed ID: 30600823
[TBL] [Abstract][Full Text] [Related]
14. Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles.
Seow WY; Xue JM; Yang YY
Biomaterials; 2007 Mar; 28(9):1730-40. PubMed ID: 17182095
[TBL] [Abstract][Full Text] [Related]
15. Dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery.
Chen D; Yu H; Sun K; Liu W; Wang H
Drug Deliv; 2014 Jun; 21(4):258-64. PubMed ID: 24102086
[TBL] [Abstract][Full Text] [Related]
16. pH-sensitive liposomes for drug delivery in cancer treatment.
Ferreira Ddos S; Lopes SC; Franco MS; Oliveira MC
Ther Deliv; 2013 Sep; 4(9):1099-123. PubMed ID: 24024511
[TBL] [Abstract][Full Text] [Related]
17. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
18. Losartan loaded liposomes improve the antitumor efficacy of liposomal paclitaxel modified with pH sensitive peptides by inhibition of collagen in breast cancer.
Xia T; He Q; Shi K; Wang Y; Yu Q; Zhang L; Zhang Q; Gao H; Ma L; Liu J
Pharm Dev Technol; 2018 Jan; 23(1):13-21. PubMed ID: 27884084
[TBL] [Abstract][Full Text] [Related]
19. Plasma stable, pH-sensitive fusogenic polymer-modified liposomes: A promising carrier for mitoxantrone.
Ghanbarzadeh S; Arami S; Pourmoazzen Z; Ghasemian-Yadegari J; Khorrami A
J Biomater Appl; 2014 Jul; 29(1):81-92. PubMed ID: 24336315
[TBL] [Abstract][Full Text] [Related]
20. Systemic Codelivery of a Homoserine Derived Ceramide Analogue and Curcumin to Tumor Vasculature Inhibits Mouse Tumor Growth.
Barui S; Saha S; Yakati V; Chaudhuri A
Mol Pharm; 2016 Feb; 13(2):404-19. PubMed ID: 26716471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]